IAVI 016

Status:Completed

Phase:I

Principal Investigator(s):

Objective:Evaluate peak T-cell response times to either an HIV-1 Clade A MVA vaccine given alone or a prime-boost regimen of a high dose of an HIV-1 Clade A DNA vaccine and an HIV-1 Clade A MVA vaccine.

Prevention Option(s):HIV Vaccine

Study Design:Controlled, Double-blind, Placebo, Randomized

Arms and Assigned Interventions

DescriptionHIV-1 Clade A MVA vaccine given alone or a prime-boost regimen of a high dose of an HIV-1 Clade A DNA vaccine and an HIV-1 Clade A MVA vaccine

Mode of Delivery

ARMsExperimental

Official Code: IAVI 016

Trial Sponsors: John Warin Ward

Start Date

End Date

none

Enrollment:24

Age range: ↔ any

Population:

Stay up-to-date!